Page 35

strength company. We focus on preventive care and do a lot of special ised tests in preventive care. We are the first lab in India to do the smal l dense LDL and HDL3 markers in India. We specialise in providing preventive care profiles at homes of people at the most affordable cost and we take pride in beDr. Dharani Subramaniam with his team at Orbito Asia, Coimbatore ing the lowest cost lab in the world, despite giving the utmost quality. Our motto is - eter repeatedly with the same device. A good analogy for un“Say yes to wellness and No to illness”. derstanding accuracy and precision is to imagine a basketball player shooting the ball into the basket. If the player shoots AGAPPE: What are the accreditations for your laboratory now? with accuracy, his aim will always take the ball close to or into Dr. Dharani: We have ISO, NABH and are awaiting NABL accredi- the basket. If the player shoots with precision, his aim will tation. always take the ball to the same location which may or may not be close to the basket. A good player will be both accurate AGAPPE: Since your entry into the diagnostic industry, as a and precise by shooting the ball the same way every time and result of continuous research and development by IVD each time making it into the basket. In today’s world, most corporates like Agappe, the industry has undergone a lot of decisions are taken by the laboratory results and so it bechanges. What are the major changes you have noticed in the comes much more necessary to be both accurate and precise. last decade as an IVD business entrepreneur and how do you find these changes helping the needy patients in Ind ia? Linearity studies are performed to determine the linear reportable range for an analyte. The linearity for each analyte is Dr. Dharani: Increasing number of lifestyle disorders like heart assessed by checking the performance of recovery throughdisease, hypertension and cancer has seen a rise in the past deout the manufacturer’s stated range of the testing system. cade. The rising awareness of prevention of these lifestyle disorThis is done using a set of standards containing varying levels ders in the population of our country has forced innovation in of an analyte in high-enough and low-enough concentrations minimally invasive and non-invasive diagnostics and this has so as to span the entire range of the test system. Linearities emerged as positive triggers in positioning India as a rapidly rising are performed whenever a new analyzer, analyte or method is market for IVD devices. The demand for clinical chemistry prodintroduced into the laboratory or an analyzer is replaced. ucts is anticipated to be vastly bolstered by advances in self-moniLinearities may also be performed for troubleshooting purtoring methods for diabetes and patient screening techniques along poses when quality control is unacceptable and deviations from with the increasing use of point-of-care systems, which offer acceptable data cannot be explained or either a major analyzer greater diagnostic accuracy and quicker results. repair or replacement of components has taken place. AGAPPE: What are your expectations from an IVD company AGAPPE: What are the facilities you are providing to pubfor the need for efficient R&D, competent manufacturing falic from your world class laboratory facilities? cility and qualitative delivery of its products and services? Dr. Dharani: Orbito Asia Diagnostics is a comprehensive Dr. Dharani: My expectation from IVD companies is to introduce newer paramaters which are available worldwide in a fast and efficient manner. That is from plan to execution and to ramp up "Orbito Asia Diagnostics is a in- house R&D facilities to be able to provide these tests at an affordable cost to our consumers. comprehensive healthcare AGAPPE: As an end user, how do you define the need for reagent’s precision, accuracy and linearity? Dr. Dharani: Accuracy describes the difference between the measurement and the parameter’s actual value while precision describes the variation you see when you measure the same param-

facility for imaging and diagnostic facilities, under one roof" Dr. Dharani says proudly.

TECHAGAPPE

APRIL-JUNE 2018

35

Techagappe 15th edition (April - June 2018) E-book  

Agappe Diagnostics Limited is the first Indian IVD company publishing an International Diagnostic News Journal “Techagappe” for the public t...

Techagappe 15th edition (April - June 2018) E-book  

Agappe Diagnostics Limited is the first Indian IVD company publishing an International Diagnostic News Journal “Techagappe” for the public t...

Advertisement